592/Multiple Sclerosis Society/United Kingdom[Grant Number] - Search Results

Year	Number of Results
2001	3
2002	3
2003	3
2004	4
2005	3
2006	1
2021	0

1

The role of nitric oxide in multiple sclerosis.

Smith KJ, Lassmann H. Smith KJ, et al. Lancet Neurol. 2002 Aug;1(4):232-41. doi: 10.1016/s1474-4422(02)00102-3. Lancet Neurol. 2002. PMID: 12849456 Review.

2

Sodium-mediated axonal degeneration in inflammatory demyelinating disease.

Bechtold DA, Smith KJ. Bechtold DA, et al. J Neurol Sci. 2005 Jun 15;233(1-2):27-35. doi: 10.1016/j.jns.2005.03.003. J Neurol Sci. 2005. PMID: 15894334 Review.

3

Axonal degeneration in multiple sclerosis: is it time for neuroprotective strategies?

Stys PK. Stys PK. Ann Neurol. 2004 May;55(5):601-3. doi: 10.1002/ana.20082. Ann Neurol. 2004. PMID: 15122698 No abstract available.

4

Nitric oxide and the axonal death cascade.

Waxman SG. Waxman SG. Ann Neurol. 2003 Feb;53(2):150-3. doi: 10.1002/ana.10397. Ann Neurol. 2003. PMID: 12557280 Review. No abstract available.

5

Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding.

Smith KJ, Hall SM. Smith KJ, et al. Curr Opin Neurol. 2001 Jun;14(3):289-98. doi: 10.1097/00019052-200106000-00005. Curr Opin Neurol. 2001. PMID: 11371750 Review.

6

Multiple sclerosis: more than inflammation and demyelination.

Rieckmann P, Smith KJ. Rieckmann P, et al. Trends Neurosci. 2001 Aug;24(8):435-7. doi: 10.1016/s0166-2236(00)01860-9. Trends Neurosci. 2001. PMID: 11488295 Review. No abstract available.

7

Axonal protection using flecainide in experimental autoimmune encephalomyelitis.

Bechtold DA, Kapoor R, Smith KJ. Bechtold DA, et al. Ann Neurol. 2004 May;55(5):607-16. doi: 10.1002/ana.20045. Ann Neurol. 2004. PMID: 15122700

8

Axonal protection achieved in a model of multiple sclerosis using lamotrigine.

Bechtold DA, Miller SJ, Dawson AC, Sun Y, Kapoor R, Berry D, Smith KJ. Bechtold DA, et al. J Neurol. 2006 Dec;253(12):1542-51. doi: 10.1007/s00415-006-0204-1. J Neurol. 2006. PMID: 17219031

9

Electrically active axons degenerate when exposed to nitric oxide.

Smith KJ, Kapoor R, Hall SM, Davies M. Smith KJ, et al. Ann Neurol. 2001 Apr;49(4):470-6. Ann Neurol. 2001. PMID: 11310624

10

Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration.

Kapoor R, Davies M, Blaker PA, Hall SM, Smith KJ. Kapoor R, et al. Ann Neurol. 2003 Feb;53(2):174-80. doi: 10.1002/ana.10443. Ann Neurol. 2003. PMID: 12557283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results